24.01.2013 Views

Erste Bank JPMorgan Merrill Lynch International

Erste Bank JPMorgan Merrill Lynch International

Erste Bank JPMorgan Merrill Lynch International

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Embedded value sensitivity analysis for the life and health insurance business*<br />

The embedded value analysis is a cash-flow analysis of life and health insurance.<br />

The embedded value consists of two components: the adjusted net assets at market value and<br />

the value of the insurance portfolio, which equals the cash value of the after-tax profit eligible for<br />

distribution minus the capital commitment cost to the solvency capital. Thus, embedded value is an<br />

actuarial quantification of the company value, assuming the continuition of current business activities<br />

(going concern), but which explicitly excludes the value of future business activities. In addition to the<br />

embedded value the increase in value induced by the new business recorded during the reporting<br />

period is calculated.<br />

The estimated trend of future profits is based on “best estimate” assumptions, e.g. a realistic<br />

appraisal of economic and operational conditions based on future expectations and historical data,<br />

whereby future risk is taken into account by the use of the risk discount rate and an explicit calculation<br />

of capital commitment costs.<br />

In order to calculate the embedded value, numerous assumptions are made about future<br />

business, operational and economic conditions, as well as other factors, some of which lie outside of<br />

the control of the Wiener Städtische Group. Although the Wiener Städtische Group considers these<br />

assumptions reasonable, future developments may differ from expectations. Thus, the publication of<br />

the embedded value is no guarantee that the expected future profits underlying this value will be<br />

realised.<br />

Based on historical and current practice, the shareholder margin from the net interest profit is set<br />

at 0.5% of the mathematical after-tax reserve (plus all risk gains), minus current profit sharing and all<br />

cost gains. There are still explicit restrictions on profit sharing in effect for certain small, mainly<br />

regulated, parts of the portfolio; these restrictions are taken into account when calculating shareholder<br />

earnings. Based on current practice, no profit sharing is assumed for the Austrian health insurance<br />

business that exceeds the amount of premium reimbursement when the obligation to perform is<br />

released. For the other sectors and markets, the amount of profit sharing assumed is based on local<br />

practice and the regulatory rules in each instance.<br />

The projections of future profits are based on realistic assumptions for proceeds from capital,<br />

inflation, costs, taxes, cancellations, mortality, illness and other key figures, such as the development<br />

of health-care costs and future increases in contributions.<br />

The proper risk discount rate of an investor or shareholder depends on their individual requirements,<br />

tax situation and an appraisal of the risks involved in realising future gains. In order to make a<br />

statement on the impact of alternative risk discount rates, the embedded value as of 30 September<br />

2005 was calculated as well as the increase in value resulting from new business in the first three<br />

quarters of 2005 with a risk discount rate increased and reduced in each instance by 1%. The table<br />

below shows the sensitivities.<br />

* The embedded value calculation was checked by Tillinghast.<br />

F-184

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!